Sanofi India Ltd.
NSE: SANOFI | BSE: 500674
₹3,163.20
₹-27.80
(-0.87%)
As on 22-May-2026IST
Market cap
₹7,289 Cr
Revenue (TTM)
₹1,774 Cr
P/E Ratio
23.5
P/B Ratio
9.3
Div. Yield
3.9 %
Quality Score
10/10
Growth Score
5/10
Valuation Score
6/10
Momentum Score
1/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹310 Cr
-
ROE
44.5 %
-
ROCE
55.5 %
-
Industry P/E
30.98
-
EV/EBITDA
14.5
-
Debt to Equity
0
-
Book Value
₹338.6
-
EPS
₹143.3
-
Face value
10
-
Shares outstanding
23,030,622
10 Years Aggregate
CFO
₹4,242.20 Cr
EBITDA
₹6,007.50 Cr
Net Profit
₹4,472.60 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Sanofi India
| -22.6 | -11.7 | -21.4 | -50.4 | -17.6 | -14.7 | -1.8 |
|
BSE Healthcare
| 8.8 | 8.8 | 9.7 | 11.0 | 27.5 | 14.1 | 12.0 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Sanofi India
| -32.9 | -24.6 | 37.8 | -25.8 | -4.6 | 18.7 | 10.5 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Sanofi India
|
3,163.2 | 7,289.3 | 1,773.8 | 309.8 | 24.0 | 43.1 | 23.5 | 9.3 |
| 3,107.5 | 38,804.4 | 5,452.9 | 1,056.0 | 22.4 | 23.9 | 36.7 | 8.6 | |
| 8,587.5 | 21,510.6 | 2,177.5 | 200.9 | 11.3 | 26.5 | 107.1 | 25.9 | |
| 2,028.0 | 15,420.9 | 2,187.2 | 649.7 | 31.5 | 19 | 24 | 4.3 | |
| 1,684.6 | 10,289.0 | 1,196.4 | 149.4 | -- | 27.5 | 55.6 | 13.8 | |
| 1,343.8 | 18,628.3 | 3,129.4 | 647.4 | 26.9 | 18.1 | 30.1 | 4.8 | |
| 2,192.6 | 35,263.5 | 4,147.8 | 709.5 | 22.3 | 18.3 | 49.7 | 8.5 | |
| 4,670.8 | 21,395.8 | 2,519.7 | 722.4 | 33.6 | 18.8 | 29.6 | 5.1 | |
| 490.3 | 9,644.1 | 1,538.1 | 226.2 | 20.4 | 9 | 39.6 | 3.9 | |
| 1,153.2 | 10,628.0 | 4,858.7 | 574.1 | 14.9 | 19.7 | 19.1 | 3.4 |
Shareholding Pattern
View DetailsNews & Analysis
All News
2 min read•By Value Research
4 min read•By Anindya Bera
4 min read•By Research Desk
3 min read•By Research Desk
About Sanofi India
Sanofi India Limited manufactures and trades in drugs and pharmaceutical products in India, Singapore and internationally. The company provides pharmaceutical products in various therapeutic areas, such as diabetes, cardiology, thrombosis,... infections, epilepsy, anti-infectives, and central nervous system, as well as allergy, pain care, digestive, and nutritional health under the Lantus, Toujeo, Soliqua, Clexane, Amaryl, Cardace, Lasix, Lasilactone, Glimepiride, Cetapin, Targocid, Frisium, Targocio, Combiflam, DePura, Allegra, Baralgan, BUSCOGAST, Dulcoflex, Enterogermina, Novalgin, and Avil brands through independent distributors. It also exports its products to approximately 24 countries. The company was formerly known as Aventis Pharma Limited and changed its name to Sanofi India Limited in May 2012. The company was incorporated in 1956 and is headquartered in Mumbai, India. Sanofi India Limited is a subsidiary of Hoechst GmbH. Read more
-
Incorporated
1956
-
Chairman
Rahul Bhatnagar
-
Managing Director
Deepak Arora
-
Group
Sanofi India - MNC
-
Headquarters
Mumbai, Maharashtra
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
Quarterly Updates
Annual Reports
Announcements
View AnnouncementsResults For The Quarter Ended 31St March 2026
28-Apr-2026No News & Announcements are available.
FAQs for Sanofi India
What is the current share price of Sanofi India Ltd Today?
The share price of Sanofi India Ltd is ₹3,163.20 (NSE) and ₹3,165.05 (BSE) as of 22-May-2026 IST. Sanofi India Ltd has given a return of -17.61% in the last 3 years.
What is the current PB & PE ratio of Sanofi India Ltd?
The P/E ratio of Sanofi India Ltd is 23.53 times as on 22-May-2026, a 24 discount to its peers’ median range of 30.98 times.
The P/B ratio of Sanofi India Ltd is 9.35 times as on 22-May-2026, a 101 premium to its peers’ median range of 4.65 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
28.81
|
13.89
|
|
2024
|
34.06
|
17.80
|
|
2023
|
30.78
|
19.59
|
|
2022
|
21.68
|
11.09
|
|
2021
|
19.22
|
8.38
|
What is the 52 Week High and Low of Sanofi India Ltd?
The 52-week high and low of Sanofi India Ltd are Rs 6,410.00 and Rs 3,157.00 as of 22-May-2026.
What is the market cap of Sanofi India Ltd?
Sanofi India Ltd has a market capitalisation of ₹ 7,289 Cr as on 22-May-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Sanofi India Ltd?
Before investing in Sanofi India Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.